OraSure Technologies Gross Margin 2010-2023 | OSUR
Current and historical gross margin for OraSure Technologies (OSUR) over the last 10 years. The current gross profit margin for OraSure Technologies as of December 31, 2023 is %.
| OraSure Technologies Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2023-12-31 | $0.41B | $0.17B | 42.22% |
| 2023-09-30 | $0.45B | $0.19B | 41.15% |
| 2023-06-30 | $0.48B | $0.19B | 39.46% |
| 2023-03-31 | $0.47B | $0.19B | 40.30% |
| 2022-12-31 | $0.39B | $0.15B | 38.50% |
| 2022-09-30 | $0.33B | $0.13B | 38.41% |
| 2022-06-30 | $0.27B | $0.10B | 37.59% |
| 2022-03-31 | $0.24B | $0.10B | 42.21% |
| 2021-12-31 | $0.24B | $0.12B | 49.79% |
| 2021-09-30 | $0.23B | $0.13B | 54.70% |
| 2021-06-30 | $0.23B | $0.14B | 60.09% |
| 2021-03-31 | $0.20B | $0.12B | 61.81% |
| 2020-12-31 | $0.17B | $0.10B | 58.72% |
| 2020-09-30 | $0.16B | $0.09B | 58.49% |
| 2020-06-30 | $0.15B | $0.09B | 57.82% |
| 2020-03-31 | $0.16B | $0.09B | 59.24% |
| 2019-12-31 | $0.16B | $0.10B | 61.29% |
| 2019-09-30 | $0.16B | $0.10B | 64.52% |
| 2019-06-30 | $0.17B | $0.11B | 64.85% |
| 2019-03-31 | $0.17B | $0.11B | 63.53% |
| 2018-12-31 | $0.18B | $0.11B | 62.64% |
| 2018-09-30 | $0.18B | $0.11B | 58.70% |
| 2018-06-30 | $0.18B | $0.10B | 57.78% |
| 2018-03-31 | $0.18B | $0.10B | 58.52% |
| 2017-12-31 | $0.17B | $0.10B | 59.28% |
| 2017-09-30 | $0.15B | $0.09B | 62.67% |
| 2017-06-30 | $0.14B | $0.09B | 65.71% |
| 2017-03-31 | $0.13B | $0.09B | 67.18% |
| 2016-12-31 | $0.13B | $0.09B | 69.29% |
| 2016-09-30 | $0.12B | $0.09B | 69.35% |
| 2016-06-30 | $0.12B | $0.08B | 68.85% |
| 2016-03-31 | $0.12B | $0.08B | 69.42% |
| 2015-12-31 | $0.12B | $0.08B | 68.07% |
| 2015-09-30 | $0.12B | $0.08B | 66.38% |
| 2015-06-30 | $0.11B | $0.08B | 65.79% |
| 2015-03-31 | $0.11B | $0.07B | 63.64% |
| 2014-12-31 | $0.11B | $0.07B | 62.62% |
| 2014-09-30 | $0.11B | $0.07B | 61.68% |
| 2014-06-30 | $0.10B | $0.06B | 59.62% |
| 2014-03-31 | $0.10B | $0.06B | 58.82% |
| 2013-12-31 | $0.10B | $0.06B | 58.59% |
| 2013-09-30 | $0.09B | $0.05B | 58.70% |
| 2013-06-30 | $0.09B | $0.05B | 59.55% |
| 2013-03-31 | $0.09B | $0.05B | 61.36% |
| 2012-12-31 | $0.09B | $0.06B | 63.64% |
| 2012-09-30 | $0.09B | $0.06B | 64.44% |
| 2012-06-30 | $0.09B | $0.06B | 64.44% |
| 2012-03-31 | $0.09B | $0.06B | 63.95% |
| 2011-12-31 | $0.08B | $0.05B | 63.41% |
| 2011-09-30 | $0.08B | $0.05B | 63.64% |
| 2011-06-30 | $0.07B | $0.05B | 63.51% |
| 2011-03-31 | $0.07B | $0.05B | 63.51% |
| 2010-12-31 | $0.08B | $0.05B | 62.67% |
| 2010-09-30 | $0.08B | $0.05B | 61.04% |
| 2010-06-30 | $0.08B | $0.05B | 61.25% |
| 2010-03-31 | $0.08B | $0.05B | 60.26% |
| 2009-12-31 | $0.08B | $0.05B | 61.04% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.420B | $0.405B |
| OraSure Technologies, Inc. develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. OraSure Technologies is the leading supplier of oral-fluid collection devices and in vitro diagnostic assays to the employment, criminal justice, drug treatment, life insurance and public health markets for the detection of abused drugs and the antibodies to HIV. Based in Bethlehem, Pennsylvania, the Company develops, manufactures and markets oral specimen collection devices, in vitro diagnostic tests, and other medical devices. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $183.756B | 24.12 |
| Stryker (SYK) | United States | $125.123B | 29.97 |
| Medtronic (MDT) | Ireland | $108.470B | 15.36 |
| Boston Scientific (BSX) | United States | $106.878B | 34.04 |
| EssilorLuxottica (ESLOY) | France | $97.379B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.753B | 0.00 |
| Haleon (HLN) | United Kingdom | $37.899B | 27.67 |
| ResMed (RMD) | United States | $31.876B | 29.93 |
| Terumo (TRUMY) | Japan | $25.923B | 36.61 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.996B | 15.99 |
| Koninklijke Philips (PHG) | Netherlands | $24.906B | 19.29 |
| Baxter (BAX) | United States | $18.734B | 13.37 |
| Insulet (PODD) | United States | $12.214B | 64.13 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.833B | 0.00 |
| Demant (WILYY) | Denmark | $10.525B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.980B | 23.77 |
| BellRing Brands (BRBR) | United States | $7.521B | 40.44 |
| Lantheus Holdings (LNTH) | United States | $5.178B | 13.04 |
| Haemonetics (HAE) | United States | $4.794B | 24.52 |
| Perrigo (PRGO) | Ireland | $4.444B | 12.71 |
| GN Store Nord (GNNDY) | Denmark | $4.368B | 24.53 |
| Prestige Consumer Healthcare (PBH) | United States | $3.475B | 16.43 |
| Envista Holdings (NVST) | United States | $3.265B | 13.48 |
| QuidelOrtho (QDEL) | United States | $2.842B | 10.32 |
| Green Thumb Industries (GTBIF) | United States | $2.777B | 88.00 |
| Neogen (NEOG) | United States | $2.604B | 25.04 |
| TG Therapeutics (TGTX) | United States | $2.502B | 70.39 |
| ICU Medical (ICUI) | United States | $2.436B | 18.18 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.255B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $1.961B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.772B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.666B | 48.83 |
| InMode (INMD) | Israel | $1.481B | 7.87 |
| National Vision Holdings (EYE) | United States | $1.402B | 43.66 |
| Owens & Minor (OMI) | United States | $1.395B | 12.14 |
| AdaptHealth (AHCO) | United States | $1.364B | 10.26 |
| Warby Parker (WRBY) | United States | $1.257B | 0.00 |
| Canopy Growth (CGC) | Canada | $1.037B | 0.00 |
| AtriCure (ATRC) | United States | $0.994B | 0.00 |
| MacroGenics (MGNX) | United States | $0.980B | 0.00 |
| Evolus (EOLS) | United States | $0.833B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.817B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.754B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.691B | 14.97 |
| Quanterix (QTRX) | United States | $0.651B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.633B | 14.99 |
| Jin Medical (ZJYL) | China | $0.561B | 0.00 |
| Valneva SE (VALN) | France | $0.537B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.514B | 0.00 |
| PetIQ (PETQ) | United States | $0.502B | 18.73 |
| Surmodics (SRDX) | United States | $0.463B | 29.01 |
| Biote (BTMD) | United States | $0.448B | 4.26 |
| ZimVie (ZIMV) | United States | $0.430B | 26.33 |
| Aurora Cannabis (ACB) | Canada | $0.368B | 0.00 |
| Zynex (ZYXI) | United States | $0.350B | 47.83 |
| Viemed Healthcare (VMD) | United States | $0.318B | 31.46 |
| Cerus (CERS) | United States | $0.300B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.280B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.257B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.244B | 15.09 |
| Veru (VERU) | United States | $0.239B | 0.00 |
| Omeros (OMER) | United States | $0.216B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.206B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.192B | 0.00 |
| High Tide (HITI) | Canada | $0.173B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.172B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.168B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.147B | 74.00 |
| Jushi Holdings (JUSHF) | United States | $0.143B | 0.00 |
| InterCure (INCR) | Israel | $0.142B | 24.00 |
| FitLife Brands (FTLF) | United States | $0.129B | 20.70 |
| Cellectar Biosciences (CLRB) | United States | $0.123B | 0.00 |
| MariMed (MRMD) | United States | $0.113B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.110B | 0.00 |
| Fonar (FONR) | United States | $0.103B | 8.86 |
| Brainsway (BWAY) | Israel | $0.096B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.095B | 0.00 |
| Chimerix (CMRX) | United States | $0.085B | 0.00 |
| Safety Shot (SHOT) | United States | $0.068B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.066B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.057B | 3.74 |
| Apyx Medical (APYX) | United States | $0.049B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.048B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.046B | 0.00 |
| Bright Green (BGXX) | United States | $0.041B | 0.00 |
| ImmuCell (ICCC) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 14.51 |
| Modular Medical (MODD) | United States | $0.035B | 0.00 |
| Exagen (XGN) | United States | $0.024B | 0.00 |
| Nephros (NEPH) | United States | $0.023B | 0.00 |
| Flora Growth (FLGC) | United States | $0.022B | 0.00 |
| Agape ATP (ATPC) | $0.021B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.017B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.016B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.015B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.010B | 72.73 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.007B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |